| 000 | 03216nam a2200361 i 4500 | ||
|---|---|---|---|
| 999 |
_c8989 _d8989 |
||
| 001 | ASIN9814411043 | ||
| 005 | 20210816161717.0 | ||
| 008 | 150204s2013 si a eng d | ||
| 020 |
_a9814411043 (hardcover) _c$149.95 |
||
| 020 | _a9789814411042 (hardcover) | ||
| 040 |
_cEG-NcFUE _erda _aEG-NcFUE _beng |
||
| 082 | 0 | 4 |
_223 _a615.6 _bN |
| 245 | 1 | 0 |
_aNanotechnology for the delivery of therapeutic nucleic acids / _cedited by Dan Peer. |
| 264 | 1 |
_aSingapore : _bPan Stanford Publishing, _c2013. |
|
| 264 | 2 |
_aLondon : _bTaylor & Francis, _c2013. |
|
| 300 |
_axiii, 226 pages ; _c23 cm |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 490 | 1 |
_aPan stanford series on biomedical nanotechnology; _vv. 4. |
|
| 500 | _apharmacy bookfair2015 | ||
| 505 | 0 | _a Lipoplexes and polyplexes : from gene delivery to gene expression / Gerardo Byk, Mirit Cohen-Ohana, and Fiana Mirkin -- 2. Cationic polymers for the delivery of therapeutic nucleotides / Wahid Khan, Saravanan Muthupandian, and Abraham J. Domb -- 3. Membrane/core nanoparticles for delivery of therapeutic nucleic acid / Younjee Chung and Leaf Huang -- 4. Delivery of single siRNA molecules / Caroline Palm-Apergi and Steven F. Dowdy -- 5. Cell-specific aptamer-functionalized RNAi : a new prospect for targeted siRNA delivery / Jiehua Zhou and John J. Rossi -- 6. Bioresponsive nanoparticles for the intracellular delivery of RNAi therapeutics / Kenneth Alan Howard -- 7. Lipid-like delivery materials for efficient siRNA delivery / James Dahlman, Robert Langer, and Michael Goldberg -- 8. Manipulation of leukocytes using therapeutic RNAi delivered by targeted and stabilized nanoparticles / Dan Peer -- 9. Lowering the siRNA delivery barrier : alginate scaffolds and immune stimulation / Jana McCaskill, Sherry Wu, Norliana Khairuddin, and Nigel A.J. McMillan. | |
| 520 | _aNucleic acid (NA) therapeutics has been extensively studied both in the academia and in the pharmaceutical industry and is still considered the promise for new therapeutic modalities, especially in personalized medicine. The only hurdle that limits the translation of NA therapeutics from an academic idea to the new therapeutic modality is the lack of efficient and safe delivery strategies. Nanotechnology for the Delivery of Therapeutic Nucleic Acids , written by world experts in the field of nanotechnology for NA delivery, the contributing authors bring together the state of the art in delivery strategies with strong emphasis on aspects that are of essence to the pharmaceutical industry, such as stability, general toxicity, immune-toxicity, pharmacokinetics, efficacy, and validation of new drug targets using unique approaches based on exquisite nanotechnology strategies. | ||
| 650 | 0 | _aDrug delivery systems. | |
| 650 | 0 | _aNucleic acids. | |
| 650 | 0 | _aNanotechnology. | |
| 700 | 1 |
_aPeer, Dan, _d1972-, _eeditor. |
|
| 830 | 0 | _aPan stanford series on biomedical nanotechnology. | |
| 856 | 4 | 0 |
_3Amazon.com _uhttp://www.amazon.com/exec/obidos/ASIN/9814411043/chopaconline-20 |
| 856 | 4 | 0 |
_3Abstract _uhttp://repository.fue.edu.eg/xmlui/handle/123456789/1742 |
| 942 |
_2ddc _cBK |
||